Neuromodulation

Type: Keyphrase
Name: Neuromodulation
First reported 19 hours ago - Updated 19 hours ago - 1 reports

Boston Scientific Reports Solid Q2 Results On Balanced Growth Across Divisions

Global medical device maker  Boston Scientific (NYSE:BSX) reported a strong set of second quarter results, with robust growth across divisions. The company’s largest division- Interventional Cardiology (IC) – reported low single-digit growth in the quarter, ... [Published Trefis - 19 hours ago]
First reported Jul 24 2014 - Updated Jul 24 2014 - 1 reports

Uroplasty Reports Fiscal First Quarter Results

/PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI), a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today reported financial results for the fiscal 2015 first quarter ended June ... [Published Bio-Medicine - Jul 24 2014]
First reported Jul 24 2014 - Updated Jul 24 2014 - 1 reports

Neuromodulation Market (Spinal Cord Stimulation (SCS), Vagus Nerve Stimulation (VNS)) worth $6.8 Billion 2017

Neuromodulation is a safe treatment for people suffering from epilepsy, Parkinson's, chronic pain, failed back surgery syndrome (FBSS/FBS), heart failure, incontinence, stroke, headache, depression, along with emerging applications for migraine, tinnitus, ... [Published Individual.com - Jul 24 2014]
First reported Jul 24 2014 - Updated Jul 24 2014 - 1 reports

Patent Issued for Integrated Delivery and Visualization Tool for a Neuromodulation System

By a News Reporter-Staff News Editor at Journal of Engineering -- From Alexandria, Virginia, VerticalNews journalists report that a patent by the inventors Pless, Benjamin David (Atherton, CA); Boling, Carl Lance (San Jose, CA); Caparso, Anthony V. (San ... [Published Crawford Financial Planning - Jul 24 2014]
First reported Jul 22 2014 - Updated Jul 22 2014 - 2 reports

Boston Scientific Neuromodulation Assigned Patent for Implantable Medical Device with Single Coil for Charging and Communicating

at 08:29 AM EDT By Targeted News Service ALEXANDRIA, Va., July 22 -- Boston Scientific Neuromodulation, Valencia, California, has been assigned a patent (8,781,596) developed by Daniel Aghassian, Glendale, California, Jordi Parramon, Valencia, ... ... [Published Industrial Info Financials - Jul 22 2014]
First reported Jul 22 2014 - Updated Jul 22 2014 - 1 reports

Does your bladder control your life? What you should know about your options

(BPT) - Do you feel like you spend your life in the bathroom? Do your night-time potty runs keep you from getting a good night's sleep? Nearly one in five adults struggles with an overactive bladder (OAB), according to the National Association for Continence ... [Published Record Delta - Jul 22 2014]
First reported Jul 21 2014 - Updated Jul 21 2014 - 1 reports

Neuromodulation by surprise: a biologically plausible model of the learning rate dynamics

Surprise is a central concept in learning, attention and the study of the neural basisof behaviour. However, how surprise affects learning and more specifically, how surpriseaffects synaptic learning rules in neural networks is largely undetermined. Here ... [Published BMC - Jul 21 2014]
First reported Jul 21 2014 - Updated Jul 21 2014 - 1 reports

St. Jude Medical Posts Second Quarter 2014 Results

St. Jude Medical reported sales and net earnings for the second quarter ended June 28. In its release on July 16, the company noted report details:Second quarter highlights:-Net sales increased 3 percent and adjusted net earnings per share increased 6 ... [Published Individual.com - Jul 21 2014]
First reported Jul 10 2014 - Updated Jul 10 2014 - 1 reports

Role of the Primary Motor Cortex in Fibromyalgia

Role of the primary motor cortex in the maintenance and treatment of pain in fibromyalgia.By L. Castillo Saavedra, M. Mendonca and F. FregniAbstract:Fibromyalgia is a highly prevalent, debilitating disease, characterized by chronic widespread pain.The ... [Published Pro Health Network - Jul 10 2014]
First reported Jul 09 2014 - Updated Jul 09 2014 - 1 reports

Methods and apparatus for intravasculary-induced neuromodulation

Methods and apparatus are provided for intravascularly-induced neuromodulation or denervation. Neuromodulation may be achieved via direct and/or via indirect application of energy or neuromodulatory agents to target neural matter, or to vascular structures ... [Published Free Patents Online - Jul 09 2014]
Entities: Neuromodulation
First reported Jul 08 2014 - Updated Jul 08 2014 - 1 reports

Boston Scientific Neuromodulation Assigned Patent for Monitoring Electrode Voltages

By Targeted News ServiceALEXANDRIA, Va. , July 7 -- Boston Scientific Neuromodulation , Valencia, California , has been assigned a patent (8,768,453) developed by three co-inventors for "[m]onitoring electrode voltages in an implantable medical device ... [Published HispanicBusiness.com - Jul 08 2014]
First reported Jun 27 2014 - Updated Jun 27 2014 - 2 reports

Global Neuromodulation Devices Market Is Expected to Reach USD 15.90 Billion in 2019: Transparency Market Research

According to a new market report published by Transparency Market Research “ Global Neuromodulation Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019", the market was valued at USD 11.16 billion in 2012, and ... [Published Digital Journal - Jun 27 2014]

Quotes

"By drawing on the collective strengths, expertise, dedication and enthusiasm of the entire Bond community - our academic staff, our talented students and our external stakeholders including the end-users of our re and the employers of our graduates - we will be able to give back to the community, to help solve society's significant and enduring health problems and ultimately build a brighter, and healthier, future for Australia" she said
...pectations, and we are reaffirming our full-year guidance today for Fiscal 2015," said Rob Kill, President and Chief Executive Officer of Uroplasty. "Global Urgent PC revenue exceeded our expectations, with stronger than expected growth in our international business. Macroplastique revenue was down slightly in the quarter, yet we continue to expect that for the full year, revenue from this product line will be similar to the past fiscal year. Continued improvement in sales force productivity, the expansion of our clinical support team to twelve individuals from the current six and our development of additional distribution channels are expected to drive Urgent PC sales growth as we look forward. At the same time, we continue to invest in our fecal incontinence clinical development program and are examining strategies to provide our sales organization with additional products that meet the unmet needs of our customer base" continued Mr. Kill
"Unfortunately, it is difficult to design the compliance voltage to an optimal level. Depending on the electrodes stimulated, the magnitude of current required for efficient therapy for a given patient, and the resistance of the patient's flesh, an optimal compliance voltage from the vantage point of power conservation is variable."

More Content

All (95) | News (77) | Reports (0) | Blogs (13) | Audio/Video (0) | Fact Sheets (4) | Press Releases (1)
sort by: Date | Relevance
Bond University appoints leading clinical resea... [Published Noodls - 14 hours ago]
Boston Scientific Reports Solid Q2 Results On B... [Published Trefis - 19 hours ago]
Uroplasty Reports Fiscal First Quarter Results [Published Bio-Medicine - Jul 24 2014]
Uroplasty Reports Fiscal First Quarter Results [Published KTUL - Jul 24 2014]
Boston Scientific Tops Q2 Earnings, Revenues; U... [Published Zacks.com - Jul 24 2014]
Neuromodulation Market (Spinal Cord Stimulation... [Published Individual.com - Jul 24 2014]
Patent Issued for Integrated Delivery and Visua... [Published Crawford Financial Planning - Jul 24 2014]
Patent Issued for Techniques for Sensing and Ad... [Published HispanicBusiness.com - Jul 24 2014]
Patent Application Titled "Current Generation A... [Published HispanicBusiness.com - Jul 24 2014]
Boston Scientific Earnings Preview: IC And CRM ... [Published Trefis - Jul 23 2014]
Louisiana Pain Specialists Becomes First in Sou... [Published PRWeb - Jul 23 2014]
Boston Scientific Neuromodulation Assigned Pate... [Published Industrial Info Financials - Jul 22 2014]
Boston Scientific Neuromodulation Assigned Pate... [Published HispanicBusiness.com - Jul 22 2014]
Does your bladder control your life? What you s... [Published Record Delta - Jul 22 2014]
Neuromodulation by surprise: a biologically pla... [Published BMC - Jul 21 2014]
Silencing Tinnitus – New Research Seeks to Redu... [Published Nutrition Review - Jul 21 2014]
St. Jude Medical Posts Second Quarter 2014 Results [Published Individual.com - Jul 21 2014]
UPDATE: St. Jude Medical Posts Higher Q2 Earnin... [Published Benzinga.com - Jul 16 2014]
Top Stocks to Watch Today: St. Jude Medical, Ab... [Published Motley Fool - Jul 16 2014]
Knowledge, Expertise, And Compassion: Premier P... [Published Scoop Asia - Jul 15 2014]
Here's What You Need to Know About Baxter Inter... [Published Motley Fool - Jul 14 2014]
Does your bladder control your life? What you s... [Published LocalSRY.com - Jul 14 2014]
Sacral nerve stimulation can help young patient... [Published Orthopedics Today - Jul 14 2014]
BOSTON SCIENTIFIC : Fitch Affirms Boston Scient... [Published 4 Traders - Jul 14 2014]
$15 million awarded to UCLA to help restore bra... [Published Medical News Today - Jul 11 2014]
Role of the Primary Motor Cortex in Fibromyalgia [Published Pro Health Network - Jul 10 2014]
U.S. Neurological Devices Market Outlook to 202... [Published Presskontakt.se - Jul 10 2014]
U.S. Neurological Devices Market Outlook to 202... [Published Wall Street Select - Jul 10 2014]
Uroplasty To Announce First Quarter Fiscal Year... [Published Noodls - Jul 10 2014]
Uroplasty To Announce First Quarter Fiscal Year... [Published TickerTech.com - Jul 10 2014]
1 2 3 4
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Enrollment Complete – 42 Patients Implanted in ... [Published Business Wire Health News - Apr 30 2014]
CHARLOTTESVILLE, Va. & TORONTO--(BUSINESS WIRE)--Functional Neuromodulation, Ltd. has completed enrollment in the ADvance study of deep brain stimulation for Alzheimer's Disease. ...
Enrollment Complete – 42 Patients Implanted in ... [Published EON Science - Apr 30 2014]
CHARLOTTESVILLE, Va. & TORONTO--(EON: Enhanced Online News)--Functional Neuromodulation, Ltd. has completed enrollment in the ADvance study of deep brain stimulation for Alzheimer's Disease. ...
Enrollment Complete – 42 Patients Implanted in ... [Published Business Wire Science: Science News - Apr 30 2014]
CHARLOTTESVILLE, Va. & TORONTO--(BUSINESS WIRE)--Functional Neuromodulation, Ltd. has completed enrollment in the ADvance study of deep brain stimulation for Alzheimer's Disease. ...
A District Court Takes an Exacting Look at Para... [Published Drug and Device Law - Apr 28 2014]
br />!--[if gte mso 9]><![endif]-->We talk a lot about preemption here.  Click on the preemption topic on the side of our webpage ( here ) and you’ll get pages and pages of posts.  That isn’t surprising.  Preemption can end a litigation, and ...
AdvaStim™ Enters Neuromodulation Device Market [Published EON Science - Apr 23 2014]
BEVERLY, Mass.--(EON: Enhanced Online News)--AdvaStim, Inc., www.advastim.com announced today that it has entered the research and development market with a new hardware/software solution for neuromodulation therapy developers. ...
1 2 3

Press Releases

sort by: Date | Relevance
Soterix Medical Inc., Rogue Resolutions Ltd., a... [Published PR Newswire - Dec 02 2013]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.